sacituzumab
gilead
['trodelvy', '$gild']
...meanwhile, this phase 2 endometiral carcinoma trodelvy study enrolled trop2 expressers (7/21 orr). since 92% of those screened showed at least some trop2 expression stage 2 of this trial is recruiting all-comers. via a santin #asco23 $gild 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.